Pandemic Latest News

Pfizer quadruples price of COVID-19 vaccines

Pfizer’s plan to quadruple US prices for its COVID-19 vaccine next year is beyond Wall Street’s expectations and will spur its revenue for years despite weaker than anticipated demand for the new booster shot so far, analysts said.

The drugmaker, which developed and sells the vaccine with Germany’s BioNTech (22UAy.DE), said on Thursday evening that it is targeting a range of $110 to $130 a dose for the vaccine once the US moves to a commercial market next year.

Analysts said the move could lead to price hikes by rivals.

The US is one of the biggest customers for the Pfizer/BioNTech COVID-19 shots.

Leave a Comment

Your email address will not be published. Required fields are marked *